Advanced search×

Effects of early therapeutic administration of interleukin-1beta on survival rate and bone marrow haemopoiesis in irradiated mice.

Acta Medica (Hradec Kralove) 53(4):221-4 (2010) PMID 21400980

The study was aimed at the experimental assessment of the efficacy of recombinant interleukin-1beta in the early therapy of haemopoiesis disorders caused by X-ray irradiation. The efficacy of the product was based on the 30-day survival rate and average life expectancy of dead animals. Endogenous and exogenous colony-formations were studied to reveal possible mechanisms of therapeutic effects of interleukin-1beta on the bone marrow. The early administration (10-15 min after exposure to radiation) of recombinant interleukin-1beta in a dose of 50 microg/kg increased the survival rate and prevented the post-irradiation decrease in the number of endogenous and exogenous CFU-S9 in irradiated mice.

Version: za2963e q8za2 q8zb3 q8zc3 q8zdb q8ze5 q8zf6 q8zg9

Similar articles you may find interesting…

  1. Characterization and favorable in vivo properties of heterodimeric soluble IL-15/IL-15Rα cytokine compared to IL-15 monomer.

    J Biol Chem (2013) PMID 23649624

    We reported that IL-15 is present as a heterodimer associated with soluble IL-15 Receptor alpha (sIL-15Ra) in the blood of mice and humans. Here, we show efficient production of this non-covalently linked but stable heterodimer in clonal human HEK293 cells and release of the processed IL-15/sIL-15R...
  2. THE FETAL SAFETY OF MACROLIDES.

    Antimicrob Agents Chemother (2013) PMID 23650169

    Use of macrolides in the first trimester of pregnancy is not associated with an increased risk of major malformations. Exposure in the third trimester is not likely to increase neonatal risks for pyloric stenosis or intussusception in a clinically meaningful manner....
  3. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as...

    J Neurosci Res (2013) PMID 23653308

    The identification of T helper 17 (Th17) cells challenges the Th1/Th2 paradigm of the immune response and invites intensive exploration of their mechanisms and functions in the field of autoimmune diseases, host defense, allergy, etc. The collective data have shown that transforming...